Literature DB >> 6155968

Oesophageal squamous cell carcinoma: I. A critical review of surgery.

R Earlam, J R Cunha-Melo.   

Abstract

Authors writing an oesophageal cancer include adenocarcinoma to a variable extent--between 1 and 75 per cent--but the true incidence of this histological type is about 1 per cent. Most adenocarcinomas are gastric in origin, involving the lower oesophagus, have a lower operative mortality than in the middle or upper one-third of the oesophagus and poorer prognosis than squamous cell carcinoma, but there is no alternative treatment to surgery. Squamous cell carcinoma of the oesophagus, separated incompletely but as far as possible, has been analysed by reviewing data on 83 783 patients in 122 paERS. After trying to standardize the data, it appears that of 100 patients with the condition, 58 will be explored and 39 have the tumour resected, of whom 13 will die in hospital. Of the 26 patients leaving hospital with the tumour excised, 18 will survive for 1 year, 9 for 2 years and 4 for 5 years. Oesophageal resection for squamous cell carcinoma has the highest operative mortality of any routinely performed surgical procedure today.

Entities:  

Mesh:

Year:  1980        PMID: 6155968     DOI: 10.1002/bjs.1800670602

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  152 in total

Review 1.  Oesophageal surgery.

Authors:  E J Simchuk; D Alderson
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis.

Authors:  Jan-Christopher Metzger; Daniel Wollschläger; Matthias Miederer; Peter Vaupel; Markus Moehler; Heinz Schmidberger; Arnulf Mayer
Journal:  Strahlenther Onkol       Date:  2017-08-02       Impact factor: 3.621

3.  Metachronous adenocarcinoma in a gastric tube after radical surgery for oesophageal cancer.

Authors:  Justyna Izabela Zygoń; Jarosław Skokowski; Jacek Zieliński; Kamil Drucis; Katarzyna Golabek-Dropiewska
Journal:  BMJ Case Rep       Date:  2010-03-11

4.  [Resection of esophageal cancer without thoracotomy by manual dissection and eversion stripping].

Authors:  J M Müller; U Zieren; A S Jerke; C Jacobi; M Adili; H Pichlmaier
Journal:  Langenbecks Arch Chir       Date:  1992

Review 5.  Minimally invasive esophagectomy.

Authors:  Fernando A Herbella; Marco G Patti
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

6.  Cancer of the oesophagus.

Authors: 
Journal:  BMJ       Date:  1990-01-27

7.  Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus.

Authors:  H Sekiguchi; S Akiyama; M Fujiwara; H Nakamura; K Kondo; Y Kasai; K Ito; J Sakamoto; H Takagi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

8.  Surgical management of esophageal cancer. A decade of change.

Authors:  J S Bolton; J L Ochsner; A A Abdoh
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

9.  Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus.

Authors:  M B Orringer
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

Review 10.  Carcinoma of the reconstructed stomach tube following esophageal resection for a benign stricture: report of a case and review of the literature.

Authors:  T Kobayashi; T Kimura; M Yoshida; S Sakuramachi; M Ohishi; Y Harada; M Yamada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.